What is it about?

This commentary discusses current issues in the use of continuous glucose monitoring and, specifically, time-in-range as a metric of glycemic control in patients with type 2 diabetes.

Featured Image

Read the Original

This page is a summary of: The Prognostic Value of Time in Range in Type 2 Diabetes, Diabetes Care, January 2021, American Diabetes Association,
DOI: 10.2337/dci20-0066.
You can read the full text:

Read

Contributors

Be the first to contribute to this page